Organization

ACUPATH LABORATORIES, INC.

According to 2025 Medicare claims, ACUPATH LABORATORIES, INC. (NPI: 1215921549) practices clinical laboratory (billing independently) in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is ACUPATH LABORATORIES, INC. (NPI: 1215921549; TIN: 113272376) and primary practice location at 11803-2309. LABORATORIES is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

The organization's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 12,836 traditional Medicare patients, billed 88,104 HCPCS/CPT codes, and received $5,987,248 in Medicare payments. The top billing code was 88312 (Special stained specimen slides to identify organisms including interpretation and report). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,092,432 to $5,987,248. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.5M$9.1M2015 Medicare payment: $4,092,432 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,988,054 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,936,291 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,217,995 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,972,470 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,367,362 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $9,092,401 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,394,994 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,461,353 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,987,248 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201512,63554,259$4,092,432
201612,99949,510$3,988,054
201714,90553,911$3,936,291
201813,20360,153$4,217,995
201914,03472,515$4,972,470
202019,31083,248$6,367,362
202123,988153,365$9,092,401
202220,296121,603$7,394,994
202314,301100,605$6,461,353
202412,83688,104$5,987,248

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

No connected Part D records

No connected Part D records

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
88312Special stained specimen slides to identify organisms including interpretation and report3,73613,317$85
88342Special stained specimen slides to examine tissue, initial procedure4,51312,880$71
88313Special stained specimen slides to examine tissue including interpretation and report4,16714,882$68
88112Cell examination of specimen, selective cellular enhancement technique2,4332,909$49
88305Pathology examination of tissue using a microscope, intermediate complexity9,32829,983$40

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for ACUPATH LABORATORIES, INC.?

Tedicare shows public-source Medicare data for ACUPATH LABORATORIES, INC. (NPI 1215921549), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does ACUPATH LABORATORIES, INC. have ACO affiliation data?

ACUPATH LABORATORIES, INC. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to ACUPATH LABORATORIES, INC.?

ACUPATH LABORATORIES, INC. is linked to ACUPATH LABORATORIES, INC. (billing NPI 1215921549) in the available physician profile data.

Does ACUPATH LABORATORIES, INC. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.